Retractable Technologies, Inc. (NYSE:RVP – Get Free Report) CEO Thomas J. Shaw bought 20,111 shares of the company’s stock in a transaction dated Tuesday, November 26th. The shares were purchased at an average price of $0.62 per share, with a total value of $12,468.82. Following the transaction, the chief executive officer now owns 14,875,244 shares of the company’s stock, valued at $9,222,651.28. The trade was a 0.14 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.
Retractable Technologies Price Performance
Shares of NYSE:RVP opened at $0.63 on Wednesday. The company has a 50 day moving average of $0.71 and a 200-day moving average of $0.92. Retractable Technologies, Inc. has a one year low of $0.56 and a one year high of $1.34. The stock has a market cap of $18.84 million, a price-to-earnings ratio of -1.16 and a beta of 1.98. The company has a debt-to-equity ratio of 0.01, a current ratio of 8.57 and a quick ratio of 5.92.
Wall Street Analyst Weigh In
Separately, StockNews.com began coverage on Retractable Technologies in a research report on Wednesday, November 27th. They issued a “hold” rating for the company.
Institutional Trading of Retractable Technologies
An institutional investor recently bought a new position in Retractable Technologies stock. PFG Investments LLC acquired a new position in shares of Retractable Technologies, Inc. (NYSE:RVP – Free Report) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned 0.12% of Retractable Technologies as of its most recent SEC filing. 7.58% of the stock is owned by institutional investors and hedge funds.
Retractable Technologies Company Profile
Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.
Featured Articles
- Five stocks we like better than Retractable Technologies
- Energy and Oil Stocks Explained
- Beyond NVIDIA: Top 5 Semiconductor Stocks to Watch for 2025
- 3 Fintech Stocks With Good 2021 Prospects
- Netflix Is On Track To Hit $1,000 By Christmas
- What is Short Interest? How to Use It
- UMAC Stock Climbs Amid Trump Jr. Appointment and Meme Stock Hype
Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with MarketBeat.com's FREE daily email newsletter.